Novel therapeutic avenues for chronic inflammatory demyelinating polyneuropathy: the difficulties of disease diversity

Yusuf Rajabally

doi:10.1016/j.ebiom.2016.03.026

Novel therapeutic avenues for chronic inflammatory demyelinating polyneuropathy: the difficulties of disease diversity

Yusuf Rajabally^*

^*Corresponding author for this work

College of Health and Life Sciences

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

Original language	English
Pages (from-to)	12-13
Number of pages	2
Journal	EBioMedicine
Volume	6
Early online date	19 Mar 2016
DOIs	https://doi.org/10.1016/j.ebiom.2016.03.026
Publication status	Published - Apr 2016

Bibliographical note

Access to Document

10.1016/j.ebiom.2016.03.026

Chronic inflammatory demyelinating
© 2016 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Final published version, 136 KBLicence: CC BY-NC-ND 3.0

Cite this

@article{a353fab8e5f34d97baca907ac2843223,

title = "Novel therapeutic avenues for chronic inflammatory demyelinating polyneuropathy: the difficulties of disease diversity",

author = "Yusuf Rajabally",

note = "{\textcopyright} 2016 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)",

year = "2016",

month = apr,

doi = "10.1016/j.ebiom.2016.03.026",

language = "English",

volume = "6",

pages = "12--13",

journal = "EBioMedicine",

publisher = "Elsevier",

}

TY - JOUR

T1 - Novel therapeutic avenues for chronic inflammatory demyelinating polyneuropathy

T2 - the difficulties of disease diversity

AU - Rajabally, Yusuf

PY - 2016/4

Y1 - 2016/4

UR - http://www.scopus.com/inward/record.url?scp=84964307832&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2016.03.026

DO - 10.1016/j.ebiom.2016.03.026

M3 - Letter, comment/opinion or interview

VL - 6

SP - 12

EP - 13

JO - EBioMedicine

JF - EBioMedicine

ER -

Novel therapeutic avenues for chronic inflammatory demyelinating polyneuropathy: the difficulties of disease diversity

Bibliographical note

Access to Document

Other files and links

Cite this